Alefacept Medicine - Information, Side effects and uses of Alefacept

Brand Name: Amevive

Alefacept is a drug which removes the immune system in order to treat the psoriasis. The scientists believe that the cause of the psoriasis is an increase in the production of the immunized cell of T-lymphocytes relative to the attachment of the antigen to the lymphocyte. While the stimulated T-lymphocytes develop quickly and cause the fast growth of the cells of skin, this produced the plates of skin of the psoriasis.

The use of the alefacept reduces the possibility of T-lymphocytes being stimulated and being produced. This is achieved by fixing with the same sector on the T-lymphocyte where antigen fasteners. Thus, the antigen is prevented binding and from activating the T-lymphocytes.

Moreover, the T-lymphocytes which were produced already lucky find their durations decreased once the therapy of alefacept starts. Alefacept does this by increasing the activity of another immunized cell which has normal qualities of killer in order to remove the T-lymphocytes.

Preparations of Alefacept

Alefacept drug is prescribed for adult patients who have moderate to severe chronic plaque psoriasis. It is available by prescription only as either an injection intramuscular of 5.0 ml or intravenous single dose vials of 7.5 mg. It must be stored at room temperatures between 59-86 degrees Fahrenheit.

What should I discuss with my healthcare provider before using alefacept?

The patients with HIV should not take the alefacept. Speak to your doctor before the catch about the alefacept if you are positive HIV.

Do not employ the alefacept without speaking to your doctor initially if you · had a preceding reaction allergic to the alefacept; the · have the heart or the problems of blood vessel; the · have cancer or a history of cancer; the · have an infection or a history of the chronic infection; or the · take another immunosuppressive drug or are reception phototherapy.

You cannot be able to employ the alefacept, or you can need an adjustment of proportioning or a special monitoring during the treatment

Alefacept is in the category B of pregnancy of FDA. This means that one does not expect that is harmful to a baby to come. Do not employ the alefacept without speaking to your doctor initially if you are pregnant or could become pregnant during the treatment

It is not known if the alefacept passes in the milk of centre. Do not employ the alefacept without speaking to your doctor initially if you nurse with the centre a baby.

Side Effects:

The side effects most common of the alefacept are throat endolorie, giddiness, cough, nausea, itching, evils of muscle, cold, pain of site of injection and redness and to inflate site of injection. The side effects most serious are a reduction of the number of immunized cells, the allergic infections, cancer and reactions. Alefacept should not be employed by the individuals whose accounts of lymphocyte of blood are less than 250/ml.

Dosage

Proportioning recommended is magnesium 7.5 magnesium by the intravenous injection or 15 by the intramuscular injection once per week during 12 weeks. The cycle of treatment can be repeated after a twelve weeks interval without treatment if the accounts of the T-lymphocyte of the patient are in the normal margin.